| Saline Hypertonic in Preschoolers (NCT02378467) | University of Washington, the Collaborative Health Studies Coordinating Center | 2015-03-01 |
| A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT) (NCT02477319) | University of Alabama at Birmingham | 2015-03-01 |
| Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study (NCT02179710) | Landon Pediatric Foundation | 2015-03-01 |
| Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease (NCT02390219) | Vertex Pharmaceuticals Incorporated | 2015-03-01 |
| Cystic Fibrosis Diagnosis by Analyzing Nasal Brushing (NCT02433132) | Assistance Publique - Hôpitaux de Paris | 2015-03-01 |
| Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes (NCT02398383) | Yale University | 2015-03-01 |
| Pregnancies and Cystic Fibrosis (NCT03290144) | Hospices Civils de Lyon | 2015-02-02 |
| A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection (NCT02453789) | AlgiPharma AS | 2015-02-01 |
| Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation (NCT02275936) | Nivalis Therapeutics, Inc. | 2015-02-01 |
| Antibiotic Nephrotoxicity in Adult Patients With Cystic Fibrosis (NCT02489955) | The Leeds Teaching Hospitals NHS Trust | 2015-02-01 |
| A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome (NCT05088447) | Stanford University | 2015-02-01 |
| Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic Fibrosis (NCT02342964) | Assistance Publique - Hôpitaux de Paris | 2015-01-08 |
| Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study (NCT02715921) | MemorialCare Health System | 2015-01-01 |
| Evaluation of the High Frequency Digit Triplet Test in Cystic Fibrosis (NCT02252601) | University of Nottingham | 2015-01-01 |
| The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients (NCT02363764) | Universitair Ziekenhuis Brussel | 2015-01-01 |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor (NCT02347657) | Vertex Pharmaceuticals Incorporated | 2015-01-01 |
| FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers (NCT02359357) | Flatley Discovery Lab LLC | 2015-01-01 |
| Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis. (NCT02847156) | Hospices Civils de Lyon | 2015-01-01 |
| HFN Versus NIV in Cystic Fibrosis. The HIFEN Study (NCT02262871) | Unity Health Toronto | 2014-12-01 |
| Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis (NCT02303808) | Universidad San Jorge | 2014-12-01 |
| Effect of a Nursing Program for Patients With Cystic Fibrosis on Disease Management (NCT02286050) | University of Zurich | 2014-11-01 |
| Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis (NCT02301377) | University of Michigan | 2014-11-01 |
| Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study (NCT04306939) | University of Pittsburgh | 2014-11-01 |
| Redox Imbalance and the Development of Cystic Fibrosis Diabetes (NCT02202876) | Emory University | 2014-11-01 |
| Resistive Inspiratory Manoeuvre as Airway Clearance Technique in Cystic Fibrosis (NCT02261987) | Universidad San Jorge | 2014-11-01 |
| Clinical Impact of MI on Inhaled Antibiotic Adherence in Cystic Fibrosis (NCT04017559) | Belfast Health and Social Care Trust | 2014-10-22 |
| Costs of Care and Adherence to Treatment for Cystic Fibrosis (NCT02832479) | Hospices Civils de Lyon | 2014-10-01 |
| Vaccination Coverage and Level of Protection in Patients at Risk (NCT03820752) | Universitaire Ziekenhuizen KU Leuven | 2014-10-01 |
| Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis (NCT02372383) | University of Colorado, Denver | 2014-10-01 |
| Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation (NCT02194881) | Assistance Publique - Hôpitaux de Paris | 2014-10-01 |
| Breath Analysis in in Adults With Cystic Fibrosis (CF) (NCT02209571) | University of Zurich | 2014-10-01 |
| A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis (NCT02157922) | AlgiPharma AS | 2014-10-01 |
| PK Study of N91115 in Cystic Fibrosis Patients (NCT02227888) | Nivalis Therapeutics, Inc. | 2014-10-01 |
| Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients (NCT02170025) | Bayer | 2014-09-30 |
| Effects of an Individualized Exercise Program on Health-related and Skill/Performance-related fitness in CF. (NCT03518697) | University Hospital, Essen | 2014-09-10 |
| Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis (NCT04397809) | National Jewish Health | 2014-09-10 |
| Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years (NCT02803944) | Hospices Civils de Lyon | 2014-09-01 |
| A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects (NCT02134353) | Syntara | 2014-09-01 |
| Social Determinants in Chronic Disease in British Columbia (NCT02203084) | University of British Columbia | 2014-09-01 |
| BioEnergetics and Metabolomics in Cystic Fibrosis (NCT02225899) | Emory University | 2014-09-01 |
| Inflammatory Markers in Broncho-alveolar Lavage Fluid as Risk Factors for Lung Disease in Infants With Cystic Fibrosis: the I-BALL Study (NCT02907788) | Erasmus Medical Center | 2014-09-01 |
| Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex (NCT02212587) | Unity Health Toronto | 2014-09-01 |
| Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period (NCT02358798) | University Hospital, Montpellier | 2014-08-19 |
| Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children (NCT02378454) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2014-08-01 |
| Glycemic Monitoring in Cystic Fibrosis (NCT02211235) | University of Colorado, Denver | 2014-08-01 |
| Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) (NCT02139306) | PTC Therapeutics | 2014-08-01 |
| First Study of Oral Cysteamine in Cystic Fibrosis (NCT02212431) | University of Aberdeen | 2014-08-01 |
| Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients (NCT02178540) | Novartis Pharmaceuticals | 2014-08-01 |
| Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis (NCT03391414) | Joseph Pilewski | 2014-08-01 |
| Effects of a Partially Supervised Conditioning Program in CF (NCT01744561) | Wuerzburg University Hospital | 2014-07-01 |
| Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens (NCT02128711) | University of Minnesota | 2014-07-01 |
| Evaluation of the Safety of the Medical Device Simeox® (NCT02061852) | Physio-Assist | 2014-07-01 |
| ATCF (Azole Therapy in Cystic Fibrosis) (NCT01576315) | Rennes University Hospital | 2014-06-01 |
| Cystic Fibrosis- Children and Adults Tai Chi Study (NCT02054377) | London South Bank University | 2014-06-01 |
| OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis (NCT02054156) | Bonnie Ramsey | 2014-06-01 |
| A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device (NCT02141191) | University of Pittsburgh | 2014-06-01 |
| Study of Ataluren (PTC124) in Cystic Fibrosis (NCT02107859) | PTC Therapeutics | 2014-05-23 |
| Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF (NCT03338595) | Augusta University | 2014-05-01 |
| A Coaching Intervention to Young Adults With Cystic Fibrosis (NCT02110914) | Rigshospitalet, Denmark | 2014-05-01 |
| The Effectiveness of a Systemic Mindfulness-based Intervention Program in a Cystic Fibrosis Clinic (NCT02131857) | Rabin Medical Center | 2014-05-01 |
| Blood Flow and Vascular Function in Cystic Fibrosis (NCT02057458) | Augusta University | 2014-04-01 |
| Muco Smartphone Exacerbation (NCT02122289) | University Hospital, Montpellier | 2014-04-01 |
| A Study to Investigate Lung Deposition of Radiolabelled OligoG (NCT01991028) | BDD Pharma Ltd | 2014-04-01 |
| Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis (NCT02141958) | Elias Matouk | 2014-04-01 |
| Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung (NCT02113397) | Dartmouth-Hitchcock Medical Center | 2014-04-01 |
| In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation (NCT02084043) | University Hospital St Luc, Brussels | 2014-03-01 |
| Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion (NCT02070744) | Vertex Pharmaceuticals Incorporated | 2014-03-01 |
| Cystic Fibrosis Related Diabetes (NCT02148978) | Ram Weiss | 2014-03-01 |
| Energy Balance and Weight Gain With Ivacaftor Treatment (NCT02141464) | Children's Hospital of Philadelphia | 2014-03-01 |
| Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (NCT01746784) | Nivalis Therapeutics, Inc. | 2014-02-01 |
| Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis (NCT01957072) | Sheffield Teaching Hospitals NHS Foundation Trust | 2014-02-01 |
| IL-17 Neutrophils in CF Lung Inflammation (NCT02025829) | University Hospitals Cleveland Medical Center | 2014-02-01 |
| CPET in CF Patients With One G551D Mutation Taking VX770 (NCT01937325) | The Alfred | 2014-02-01 |
| Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF) (NCT02039986) | Children's Hospital of Philadelphia | 2014-01-06 |
| Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF (NCT02109822) | University of Washington | 2014-01-01 |
| Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles (NCT02015663) | Novartis Pharmaceuticals | 2014-01-01 |
| PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis (NCT02419989) | National Jewish Health | 2014-01-01 |
| Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis (NCT02847208) | Hospices Civils de Lyon | 2014-01-01 |
| An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor (NCT02015507) | Vertex Pharmaceuticals Incorporated | 2014-01-01 |
| G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) (NCT01521338) | Steven M Rowe | 2014-01-01 |
| Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis (NCT02048163) | Dayton Children's Hospital | 2013-12-01 |
| Investigating the Incretin Effect in Cystic Fibrosis (NCT01975259) | Liverpool Heart and Chest Hospital NHS Foundation Trust | 2013-12-01 |
| Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation (NCT01946412) | Vertex Pharmaceuticals Incorporated | 2013-12-01 |
| Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis (NCT01958944) | Beyond Air Inc. | 2013-12-01 |
| Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis (NCT00924547) | Vanderbilt University | 2013-11-01 |
| Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution (NCT02038803) | Rush University Medical Center | 2013-10-10 |
| Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified (NCT02526004) | University College Cork | 2013-10-01 |
| Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients (NCT01784419) | University of California, San Francisco | 2013-10-01 |
| Zoledronic Acid in Cystic Fibrosis (NCT01702415) | Papworth Hospital NHS Foundation Trust | 2013-10-01 |
| Comparison of Absorption of Vitamin D in Cystic Fibrosis (NCT01880346) | Emory University | 2013-10-01 |
| Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects (NCT01953367) | Pari Pharma GmbH | 2013-09-01 |
| Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability (NCT01615484) | University of North Carolina, Chapel Hill | 2013-09-01 |
| Impact of Immunonutrition on the Patients With Cystic Fibrosis (NCT02048592) | University Hospital, Motol | 2013-09-01 |
| A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic Fibrosis (NCT01923753) | Actegy Ltd. | 2013-09-01 |
| Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis (NCT02003079) | St. Paul's Hospital, Canada | 2013-09-01 |
| Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients (NCT01944735) | Celtaxsys, Inc. | 2013-09-01 |
| Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy (NCT01858519) | AbbVie | 2013-08-01 |
| Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI) (NCT01844778) | Novartis Pharmaceuticals | 2013-08-01 |
| Evaluation of Food Insecurity in Adults and Children With Cystic Fibrosis (NCT03318328) | Dixie Durham | 2013-08-01 |
| LAIV (Flumist®) Administration in CF Patients (NCT01885169) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2013-08-01 |